tradingkey.logo

Ipsen: Impact Of Iqirvo On Fatigue

ReutersMay 7, 2025 6:04 AM

- Ipsen SA IPN.PA:

  • LATE-BREAKING EXPLORATORY DATA HIGHLIGHTS THE IMPACT OF IQIRVO® (ELAFIBRANOR) ON FATIGUE AND PROVIDES MECHANISTIC INSIGHTS INTO ANTI-INFLAMMATORY AND SYMPTOM-RELATED EFFECTS IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS

  • IQIRVO DUAL PPARΑ/Δ ACTIVATION IMPACTS INFLAMMATION AND FIBROSIS

  • PPARΑ ACTIVATION LINKED TO FATIGUE IMPROVEMENT IN PRIMARY BILIARY CHOLANGITIS

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI